ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,313Medicare Part D Prescriptions Filled, Including Refills

Rank: 281 out of 890

$475K Total Retail Price of All Prescriptions

Rank: 260 out of 890

358 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,846 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 314 256 1 5
LEVOTHYROXINE SODIUM 272 191 2 2
AMLODIPINE BESYLATE 249 226 3 1
METFORMIN HCL 221 205 4 6
FUROSEMIDE 180 152 5 7
SYNTHROID 169 130 6 53
WARFARIN SODIUM 169 165 6 24
HYDROCHLOROTHIAZIDE 163 151 8 9
POTASSIUM CHLORIDE 163 148 8 11
LISINOPRIL 148 122 10 4
DIOVAN 143 139 11 33
ATORVASTATIN CALCIUM 140 116 12 13
PANTOPRAZOLE SODIUM 135 122 13 34
OMEPRAZOLE 135 110 13 8
GABAPENTIN 131 131 15 12
ATENOLOL 126 114 16 23
PRAVASTATIN SODIUM 115 85 17 10
TRAMADOL HCL 109 84 18 16
METOPROLOL SUCCINATE 108 107 19 17
FLUOXETINE HCL 105 88 20 63
NEXIUM 103 57 21 14
LOSARTAN POTASSIUM 94 94 22 29
TRAZODONE HCL 82 70 23 40
ALENDRONATE SODIUM 75 64 24 38
SERTRALINE HCL 71 52 25 26
METOPROLOL TARTRATE 71 60 25 15
CLONIDINE HCL 69 32 27 35
CELEBREX 68 62 28 91
CARVEDILOL 66 66 29 22
BUMETANIDE 61 61 30 134
HYDROCODONE-ACETAMINOPHEN 57 52 S3 31 3
BENAZEPRIL HCL 57 41 31 44
DONEPEZIL HCL 56 56 33 30
AMITIZA 56 35 33 210
ZETIA 56 54 33 81
JANUVIA 56 55 33 59
ROPINIROLE HCL 56 16 33 93
CITALOPRAM HBR 54 31 38 20
NAMENDA 53 41 39 36
CRESTOR 53 52 39 25
AZITHROMYCIN 51 40 41 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.